Mason John O, Shah Ami A, Vail Rachel S, Nixon Peter A, Ready Edgar L, Kimble James A
Retina Consultants of Alabama, Callahan Eye Foundation Hospital, 700 South 18th Street, Birmingham, AL 35233, USA.
Am J Ophthalmol. 2008 Sep;146(3):455-7. doi: 10.1016/j.ajo.2008.05.009. Epub 2008 Jul 2.
To evaluate the visual prognosis in eyes with branch retinal artery occlusion (BRAO).
Retrospective, observational, consecutive case series.
Retrospective medical record review of 52 consecutive eyes of 52 patients with BRAO seen at two vitreoretinal practices in Birmingham, Alabama. Only eyes with decreased central macular perfusion on fluorescein angiography (FA) were included. Eyes with anterior segment or optic nerve disease, lack of retinal whitening or a delay in arterial filling on FA, central retinal artery occlusion, and cilioretinal artery occlusion were excluded. The main outcome measure was presenting best-corrected visual acuity (BCVA) and its relationship to final BCVA.
On presentation, 54% of eyes with BRAO had BCVA of 20/40 or better. At the mean 14-month visit, 60% of all eyes had visual acuity (VA) of 20/40 or better. VAs of 20/40 or better were retained by 89% of eyes with baseline BCVA of 20/40 or better. Only 14% of eyes with 20/100 or worse BCVA improved to 20/40 or better. Neither visible emboli (P > or = .244) nor the region of macular involvement (P = .142) were significant with respect to visual improvement.
Visual prognosis after BRAO seems to be correlated to presenting VA. Eyes with initial VA of 20/40 or better usually remained at 20/40 or better. Individuals with poor VA of 20/100 or worse generally did not show the significant improvement reported in previous studies.
评估视网膜分支动脉阻塞(BRAO)患者眼睛的视力预后。
回顾性、观察性、连续病例系列研究。
对阿拉巴马州伯明翰市两家玻璃体视网膜诊所的52例BRAO患者的52只眼睛进行回顾性病历审查。仅纳入荧光素血管造影(FA)显示黄斑中心灌注降低的眼睛。排除患有眼前节或视神经疾病、FA检查时视网膜无变白或动脉充盈延迟、视网膜中央动脉阻塞和睫状视网膜动脉阻塞的眼睛。主要观察指标为就诊时的最佳矫正视力(BCVA)及其与最终BCVA的关系。
就诊时,54%的BRAO患者眼睛的BCVA为20/40或更好。在平均14个月的随访中,所有眼睛中有60%的视力(VA)为20/40或更好。基线BCVA为20/40或更好的眼睛中,89%保持了20/40或更好的视力。BCVA为20/100或更差的眼睛中,只有14%改善到20/40或更好。可见栓子(P≥0.244)和黄斑受累区域(P = 0.142)在视力改善方面均无显著意义。
BRAO后的视力预后似乎与就诊时的VA相关。初始VA为20/40或更好的眼睛通常保持在20/40或更好。VA为20/100或更差的个体通常未显示出先前研究中报道的显著改善。